Cardiogenic shock can occur due to acute ischaemic or non-ischaemic cardiac events, or
from progression of long-standing underlying heart disease. When addressing the cause of …

Background: There are contrasting reports on the effectiveness of a concomitant intra-aortic
balloon pump (IABP) in cardiogenic shock patients treated with veno-arterial extracorporeal …

Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a widely
used form of mechanical circulatory support in patients with refractory cardiogenic shock. A …

Background: Veno-arterial extracorporeal life support (VA-ECLS) is widely used to treat
refractory cardiogenic shock. However, increased left ventricular (LV) afterload in VA-ECLS …

Background Clinical outcomes of acute myocardial infarction complicated by cardiogenic
shock remain poor with high in‐hospital mortality. Veno‐arterial extracorporeal membrane …

TCS have become the cornerstone of the management of patients with cardiogenic shock,
although the evidence supporting their efficacy is limited. VA-ECMO is considered the first …

Background Outcomes of patients requiring venoarterial extracorporeal membrane
oxygenation (VA-ECMO) vary greatly by etiology, but large studies that incorporate the …

Aims: The aim of this study was to evaluate the Impella CP over veno-arterial extracorporeal
membrane oxygenation (VA-ECMO) and their impact on left ventricular unloading and end …

Background Incidence and mortality of cardiogenic shock (CS) in patients with acute
myocardial infarction (AMI) remain high despite substantial therapy improvements in acute …

Aims We investigated the spectrum of emergency veno-arterial extracorporeal membrane
oxygenation (VA ECMO)-supported interventions including percutaneous coronary …